INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 448m ago
HOUSE PTR48m ago
SEC 13F48m ago
ROBINHOOD CHAIN48m ago
KV
Corporate insider

Klemp Walter V

Director, CEO and PresidentCIK 0000938419

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Option exercise
M—
57 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Moleculin Biotech, Inc.Director, CEO and President · Nov 6, 2026
9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Tax withholding
F
$118
14 sh
Nov 4, 2026
Nov 6, 2026
traded Nov 4, 2026
+2d
SEC FORM 4

Evidence

9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Option exercise
M—
57 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence